Dr. Robert Leo Wellner, DO

Dr. Wellner practices at Northern New Jersey Eye Institute in South Orange, New Jersey.

Dr. Wellner's NPI, 1790862977, was assigned on November 1, 2006. Dr. Wellner holds Pennsylvania license OS011916.

Dr. Wellner's primary practice is Northern New Jersey Eye Institute, at 71 Second Street, South Orange, NJ 07079. The practice phone is (973) 763-2203.

Dr. Wellner's primary practice is Northern New Jersey Eye Institute in South Orange, New Jersey. The medical group on file is Allied Digestive Health. Dmand AI also links Dr. Wellner to 9 more medical groups, 3 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wellner practices, 5 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Wellner's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dmand AI has Dr. Wellner's licenses on file in 3 states: Pennsylvania, California and New Jersey.

CMS data shows 436 Medicare services from Dr. Wellner across 6 procedure codes in 2024, for 368 Medicare patients. Medicare paid $41,662 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 368 Medicare patients who saw Dr. Wellner in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wellner's median patient age at 70, with 64% women.

In 2018, Dr. Wellner wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $423 in total drug cost. In 2017, CMS named 72 claims across 5 drugs.

Dr. Wellner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Wellner from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Pacira Pharmaceuticals Incorporated paid the most, $25.